Wollenberg, A., de Bruin-Weller, M., Thyssen, J. P., Beck, L. A., Simpson, E. L., Imafuku, S., Boguniewicz, M., Kurbasic, A., Soldbro, L., Strange Vest, N., Arlert, P., & Paller, A. S. (2022). Conjunctivitis in adolescent patients aged 12–17 with moderate-to-severe atopic dermatitis treated with tralokinumab up to week 52: results from the phase 3 ECZTRA 6 trial. SKIN The Journal of Cutaneous Medicine, 6(6), s75. https://doi.org/10.25251/skin.6.supp.75